Failed Moderate Sedation During Procedure Clinical Trial
Official title:
Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study
The purpose of this study is to evaluate the feasibility of intranasal ketamine for adequate sedation of children undergoing minor procedures in the Emergency Department. An intranasal dose of 10mg/kg will be used in patients requiring procedural sedation. The investigators hypothesize that this dose of intranasal ketamine will be able to provide adequate sedation and analgesia for the physician to successfully complete the planned diagnostic or therapeutic intervention (Pediatr Emer Care 2012;28: 767-70). The primary endpoint will be successful sedation, as defined by the ability to complete the planned procedure without rescue medication, which includes re-dosing of the same medication.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04701008 -
Efficacy of Ketamine in Post Anesthesia Recovery Room
|
||
| Recruiting |
NCT04490031 -
Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)
|
Phase 4 | |
| Completed |
NCT00486902 -
Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?
|
N/A | |
| Completed |
NCT03525912 -
Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions
|
N/A | |
| Completed |
NCT03979105 -
Cardiovascular Safety After Continuous Ketamine Infusion
|